Virtify, Inc., a Cambridge, MA-based provider of enterprise content compliance software solutions, has secured $15m in growth equity financing.
The round was led by Tudor Ventures.
Virtify helps organizations reduce time, risk, and costs by managing and automating the complex regulatory compliance and content exchange requirements throughout the product life cycle.
The company will use the new funds to accelerate the entrance of its Virtx enterprise content compliance software suite into the life sciences market by expanding operations, engineering, sales and marketing initiatives.
This expansion will take place in the U.S., Europe, and other key markets.
Virtx supports life sciences businesses in cutting the cost of bringing a new drug to market by providing a web-based environment for managing regulated content throughout the entire process – from pre-clinical through product registration to commercialization.